We have 3 of 9 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
AI-integrated approaches represent a paradigm shift in liposome development, offering accelerated formulation design, enhanced scalability, and improved prospects for reliable clinical translation.
Sunvozertinib provides a compelling pharmacological option that bridges long-standing unmet needs in precision thoracic oncology and explores frontline positioning against systemic chemo-immunotherapy combinations, while companion biomarker discovery aims to define individualized treatment sequencing.
RNA-based theranostic strategies show promising potential for glioma therapy, however, further optimization of delivery systems, improved safety profiles, and successful clinical translation remain necessary.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
